ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,493, issued on Sept. 30, was assigned to LAVA THERAPEUTICS N.V. (Utrecht, Netherlands).

"Antibodies that bind PSMA and gamma-delta T cell receptors" was invented by Robertus Cornelis Roovers (Utrecht, Netherlands), Johannes Jelle Van Der Vliet (Amsterdam), Lisa Anna King (Amsterdam), Paul Willem Henri Ida Parren (Utrecht, Netherlands), Victoria Iglesias Guimarais (Utrecht, Netherlands), David Lutje Hulsik (Utrecht, Netherlands) and Peter Alexander Gerardus Maria Machielsen (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies capable of binding human PSMA and capable of binding a human VGam...